New Zealand markets closed

MaxCyte Inc (MYE0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
4.1400+0.0200 (+0.49%)
At close: 03:41PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
41,990
41,288
44,261
33,894
26,169
-
Cost of revenue
4,778
4,742
5,098
3,647
2,767
-
Gross profit
37,212
36,546
39,163
30,247
23,402
-
Operating expenses
Research development
17,167
23,817
19,514
15,407
17,735
-
Selling general and administrative
43,575
57,043
44,482
31,679
15,699
-
Total operating expenses
62,778
84,845
66,524
48,435
34,459
-
Operating income or loss
-25,565
-48,299
-27,361
-18,189
-11,057
-
Interest expense
116
-
126.9
1,044
825.6
681.1
Total other income/expenses net
-
-
-127
-
-
-
Income before tax
-23,636
-37,923
-23,571
-19,082
-11,816
-
Income tax expense
-
0
0
0
-
-
Income from continuing operations
-23,636
-37,923
-23,571
-19,082
-11,816
-
Net income
-23,636
-37,923
-23,571
-19,082
-11,816
-
Net income available to common shareholders
-23,636
-37,923
-23,571
-19,082
-11,816
-
Basic EPS
-0.37
-
-0.23
-0.21
-0.17
-0.23
Diluted EPS
-0.37
-
-0.23
-0.21
-0.17
-0.23
Basic average shares
102,878
-
101,703
90,619
69,465
56,398
Diluted average shares
102,878
-
101,703
90,619
69,465
56,398